nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—NGF—atopic dermatitis	0.333	0.485	CrCbGaD
Bupranolol—Gemfibrozil—PPARA—atopic dermatitis	0.288	0.421	CrCbGaD
Bupranolol—Clenbuterol—TNF—atopic dermatitis	0.0645	0.0941	CrCbGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00672	0.0214	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—NPS—atopic dermatitis	0.0066	0.021	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00599	0.019	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00537	0.0171	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL22—atopic dermatitis	0.00512	0.0163	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—CXCR3—atopic dermatitis	0.00481	0.0153	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL27—atopic dermatitis	0.00456	0.0145	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00433	0.0138	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00412	0.0131	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL17—atopic dermatitis	0.00409	0.013	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00399	0.0127	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—NPS—atopic dermatitis	0.00392	0.0125	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.0039	0.0124	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—NPS—atopic dermatitis	0.00383	0.0122	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.0036	0.0114	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00356	0.0113	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00353	0.0112	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00348	0.0111	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL11—atopic dermatitis	0.0033	0.0105	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00319	0.0101	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00315	0.01	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00315	0.01	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00312	0.00991	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00309	0.00981	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL22—atopic dermatitis	0.00304	0.00965	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—CCR5—atopic dermatitis	0.00302	0.00959	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL22—atopic dermatitis	0.00297	0.00944	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL27—atopic dermatitis	0.00271	0.00861	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR3—atopic dermatitis	0.00269	0.00854	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL27—atopic dermatitis	0.00265	0.00842	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL22—atopic dermatitis	0.00263	0.00835	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCL27—atopic dermatitis	0.00258	0.00819	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00257	0.00817	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00251	0.00799	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00249	0.00793	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00245	0.00777	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL17—atopic dermatitis	0.00243	0.00772	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—NPS—atopic dermatitis	0.0024	0.00762	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—TAC1—atopic dermatitis	0.0024	0.00762	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00239	0.0076	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL17—atopic dermatitis	0.00238	0.00755	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCR3—atopic dermatitis	0.00235	0.00747	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL27—atopic dermatitis	0.00234	0.00744	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00226	0.00718	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00215	0.00682	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00214	0.00679	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL17—atopic dermatitis	0.0021	0.00667	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.0021	0.00666	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00209	0.00665	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00205	0.00651	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL11—atopic dermatitis	0.00196	0.00622	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00193	0.00615	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL11—atopic dermatitis	0.00191	0.00609	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL10—atopic dermatitis	0.0019	0.00604	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00187	0.00594	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00187	0.00594	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00183	0.00582	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00183	0.00581	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00183	0.00581	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00179	0.00569	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL11—atopic dermatitis	0.00169	0.00538	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FCER2—atopic dermatitis	0.00167	0.0053	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL5—atopic dermatitis	0.00164	0.0052	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR3—atopic dermatitis	0.0016	0.00507	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR3—atopic dermatitis	0.00156	0.00496	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL22—atopic dermatitis	0.00156	0.00495	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL22—atopic dermatitis	0.00155	0.00493	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00153	0.00486	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL22—atopic dermatitis	0.00153	0.00485	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR3—atopic dermatitis	0.00152	0.00483	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCL27—atopic dermatitis	0.0015	0.00476	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00148	0.00471	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR5—atopic dermatitis	0.00147	0.00468	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00145	0.0046	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TAC1—atopic dermatitis	0.00142	0.00452	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—NPS—atopic dermatitis	0.00142	0.00452	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00139	0.00443	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—NPS—atopic dermatitis	0.00139	0.00442	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TAC1—atopic dermatitis	0.00139	0.00442	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL27—atopic dermatitis	0.00139	0.00442	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL27—atopic dermatitis	0.00138	0.0044	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR3—atopic dermatitis	0.00138	0.00438	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00136	0.00434	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL27—atopic dermatitis	0.00136	0.00432	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TAC1—atopic dermatitis	0.00135	0.0043	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—NPS—atopic dermatitis	0.00135	0.0043	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00134	0.00426	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00133	0.00422	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00131	0.00417	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00127	0.00405	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL5—atopic dermatitis	0.00126	0.004	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00125	0.00396	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL17—atopic dermatitis	0.00125	0.00396	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL17—atopic dermatitis	0.00124	0.00394	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NPS—atopic dermatitis	0.00123	0.00391	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TAC1—atopic dermatitis	0.00123	0.00391	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL17—atopic dermatitis	0.00122	0.00387	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCR3—atopic dermatitis	0.00121	0.00383	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00117	0.00372	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00115	0.00365	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL5—atopic dermatitis	0.00114	0.00363	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00113	0.00358	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00112	0.00357	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KIF3A—atopic dermatitis	0.00111	0.00351	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL10—atopic dermatitis	0.0011	0.00351	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00107	0.00341	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL11—atopic dermatitis	0.001	0.00319	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CMA1—atopic dermatitis	0.001	0.00318	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL11—atopic dermatitis	0.001	0.00318	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FCER2—atopic dermatitis	0.000991	0.00315	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL11—atopic dermatitis	0.000983	0.00312	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL10—atopic dermatitis	0.000975	0.0031	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL5—atopic dermatitis	0.000971	0.00308	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FCER2—atopic dermatitis	0.000969	0.00308	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL5—atopic dermatitis	0.000949	0.00302	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT6—atopic dermatitis	0.00094	0.00299	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCL5—atopic dermatitis	0.000924	0.00294	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	0.000921	0.00293	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000902	0.00287	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	0.000901	0.00286	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL8—atopic dermatitis	0.000891	0.00283	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000882	0.0028	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	0.000874	0.00278	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	0.000855	0.00272	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL5—atopic dermatitis	0.000839	0.00267	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR5—atopic dermatitis	0.000833	0.00265	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	0.000821	0.00261	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	0.000819	0.0026	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR3—atopic dermatitis	0.000815	0.00259	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000804	0.00255	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	0.000804	0.00255	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	0.000803	0.00255	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	0.000801	0.00255	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000788	0.00251	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	0.000786	0.0025	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000786	0.0025	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000771	0.00245	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR5—atopic dermatitis	0.000756	0.0024	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	0.000747	0.00237	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	0.000736	0.00234	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	0.000731	0.00232	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	0.00073	0.00232	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	0.00073	0.00232	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAC1—atopic dermatitis	0.000726	0.00231	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NPS—atopic dermatitis	0.000726	0.00231	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	0.00072	0.00229	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000716	0.00227	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	0.000714	0.00227	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	0.000714	0.00227	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCR3—atopic dermatitis	0.000712	0.00226	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	0.0007	0.00223	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000694	0.00221	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000679	0.00216	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	0.000679	0.00216	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL5—atopic dermatitis	0.000675	0.00215	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	0.000664	0.00211	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	0.000656	0.00209	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	0.000642	0.00204	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000637	0.00202	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000623	0.00198	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	0.000593	0.00189	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	0.000593	0.00189	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	0.000581	0.00184	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	0.000581	0.00184	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000579	0.00184	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL10—atopic dermatitis	0.000576	0.00183	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000566	0.0018	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	0.000558	0.00177	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000548	0.00174	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	0.000546	0.00173	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000537	0.00171	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000529	0.00168	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000517	0.00164	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000503	0.0016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	0.000498	0.00158	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL5—atopic dermatitis	0.000496	0.00158	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000494	0.00157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	0.000487	0.00155	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	0.000484	0.00154	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000483	0.00154	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL2—atopic dermatitis	0.000481	0.00153	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	0.000473	0.0015	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NGF—atopic dermatitis	0.000459	0.00146	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—atopic dermatitis	0.000457	0.00145	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	0.000449	0.00143	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR5—atopic dermatitis	0.000447	0.00142	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	0.000439	0.00139	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL2—atopic dermatitis	0.000437	0.00139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	0.000431	0.00137	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NPS—atopic dermatitis	0.000431	0.00137	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	0.000423	0.00134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NPS—atopic dermatitis	0.000422	0.00134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	0.000422	0.00134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	0.000414	0.00131	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL5—atopic dermatitis	0.000401	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL5—atopic dermatitis	0.000392	0.00125	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NFKBIA—atopic dermatitis	0.000379	0.0012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	0.000342	0.00109	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	0.000334	0.00106	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000299	0.000949	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	0.000294	0.000935	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000292	0.000929	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	0.000288	0.000915	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	0.000286	0.000907	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	0.000279	0.000888	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGF—atopic dermatitis	0.000272	0.000866	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000271	0.000862	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—atopic dermatitis	0.00027	0.000858	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGF—atopic dermatitis	0.000267	0.000847	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000265	0.000843	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	0.000265	0.000842	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	0.000259	0.000824	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	0.000259	0.000824	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2—atopic dermatitis	0.000258	0.00082	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—atopic dermatitis	0.000257	0.000816	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	0.000254	0.000806	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK8—atopic dermatitis	0.000238	0.000755	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000225	0.000714	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	0.00022	0.000699	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	0.00016	0.000509	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	0.000157	0.000498	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2—atopic dermatitis	0.000153	0.000487	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	0.000152	0.000484	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—atopic dermatitis	0.000152	0.000482	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2—atopic dermatitis	0.00015	0.000476	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	0.000149	0.000474	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	0.000141	0.000448	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	0.000138	0.000438	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—atopic dermatitis	9e-05	0.000286	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—atopic dermatitis	8.81e-05	0.00028	CbGpPWpGaD
